1. 'Know thyself' – host factors influencing cancer response to immune checkpoint inhibitors. Issue 4 (20th May 2022) Authors: Gunjur, Ashray; Manrique‐Rincón, Andrea J; Klein, Oliver; Behren, Andreas; Lawley, Trevor D; Welsh, Sarah J; Adams, David J Journal: Journal of pathology Issue: Volume 257:Issue 4(2022) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Accumulation of CD103+ CD8+ T cells in a cutaneous melanoma micrometastasis. Issue 12 (25th December 2019) Authors: Hochheiser, Katharina; Aw Yeang, Han Xian; Wagner, Teagan; Tutuka, Candani; Behren, Andreas; Waithman, Jason; Angel, Christopher; Neeson, Paul J; Gebhardt, Thomas; Gyorki, David E Journal: Clinical & translational immunology Issue: Volume 8:Issue 12(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer. (4th November 2015) Authors: Woods, Katherine; Schittenhelm, Ralf B; Heesterbeek, Dani; Knights, Ashley; Anaka, Matthew; Purcell, Anthony W; Behren, Andreas; Cebon, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer. Issue 2 (December 2015) Authors: Woods, Katherine; Schittenhelm, Ralf; Heesterbeek, Dani; Knights, Ashley; Anaka, Matthew; Purcell, Anthony; Behren, Andreas; Cebon, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538. (1st January 2021) Authors: Klein, Oliver; Senko, Clare; Carlino, Matteo S; Markman, Ben; Jackett, Louise; Gao, Bo; Lum, Caroline; Kee, Damien; Behren, Andreas; Palmer, Jodie; Cebon, Jonathan Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evolving role of tumor antigens for future melanoma therapies. (June 2014) Authors: Andrews, Miles C; Woods, Katherine; Cebon, Jonathan; Behren, Andreas Journal: Future oncology Issue: Volume 10:Number 8(2014) Page Start: 1457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evolving role of tumor antigens for future melanoma therapies. (June 2014) Authors: Andrews, Miles C; Woods, Katherine; Cebon, Jonathan; Behren, Andreas Journal: Future oncology Issue: Volume 10:Number 8(2014) Page Start: 1457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Flt3 ligand expands CD4+FoxP3+ regulatory T cells in human subjects. Issue 2 (5th December 2012) Authors: Klein, Oliver; Ebert, Lisa M.; Zanker, Damien; Woods, Katherine; Tan, Bee Shin; Fucikova, Jitka; Behren, Andreas; Davis, Ian D.; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan Journal: European journal of immunology Issue: Volume 43:Issue 2(2013:Feb.) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment. (August 2014) Authors: Vella, Laura J; Andrews, Miles C; Behren, Andreas; Cebon, Jonathan; Woods, Katherine Journal: Expert review of clinical immunology Issue: Volume 10:Number 8(2014) Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Is there a role for combined anti–PD‐1/CTLA‐4 checkpoint blockade in the management of advanced biliary tract cancers?. Issue 7 (24th January 2023) Authors: Klein, Oliver; Kee, Damien; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Behren, Andreas; Palmer, Jodie; Tebbutt, Niall C.; Carlino, Matteo S.; Cebon, Jonathan Journal: Cancer Issue: Volume 129:Issue 7(2023) Page Start: 1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗